1. DOP06 Dynamic shifts in the balance of gut homing Treg and Th17 cells play a critical role in ulcerative colitis and may predict response to vedolizumab therapy. (25th January 2019) Authors: Hermangild Kottoor, S; Kassam, Z; Pavlidis, P; Alberts, E; Ibraheim, H; Constable, L; Digby-Bell, J; Warren, D; Odukwe, S; Samaan, M; Irving, P; Sanderson, J; Powell, N Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S030 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP075 Colonic gamma delta t-cells respond innately to NKG2D ligands and are grossly dysregulated in active inflammatory bowel disease. (16th January 2018) Authors: Dart, R J; Vantourout, P; Laing, A; Digby-Bell, J; Powell, N; Irving, P; Hayday, A Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S081 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP60 The interleukin 22 transcriptional programme is activated in human colonic inflammation and associated to anti-TNFα primary non-response in Crohn's. (25th January 2019) Authors: Pavlidis, P; Tsakmaki, A; Niazi, U; Digby-Bell, J; Lombardi, G; Hayee, B; Bewick, G; Powell, N Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P083 The transcriptomic signature of IL-23-treated lamina propria mononuclear cells is significantly enriched for genes in the Th17 pathway and is enriched in active UC. (25th January 2019) Authors: Digby-Bell, J; Pavlidis, P; Niazi, U; Kassam, Z; Prescott, N; Perucha, E; Saqi, M; Powell, N Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P25 Fragility fracture risk in cirrhosis: a comparison of the fracture risk assessment tool (FRAX_), BSG and NICE guidelines. (6th September 2011) Authors: Ayres, L; Digby-Bell, J; Clarke, S; Dhanda, A; Caddick, K; Collins, P Journal: Gut Issue: Volume 60:(2011)Supplement 2 Page Start: A11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P594 Utilisation of anti-TNF agents in phlegmonous Crohn's disease: an Australian tertiary referral centre experience. (27th May 2021) Authors: Chiu, L; Digby-Bell, J; Seah, J; Melton, S; Taylor, K; Sparrow, M Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PTH-053 Factors Influencing Infliximab and Adalimumab Antibody Formation and 6 Month Retrospective Follow-Up in A Tertiary IBD Centre. (17th August 2016) Authors: Warner, BD; Johnston, E; Digby-Bell, J; Arkir, Z; Unsworth, N; Anderson, S; Sanderson, J; Irving, P Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PTU-062 Vedolizumab: Early Experience and Medium-Term Follow up Data from Two UK Tertiary IBD Centres. (17th August 2016) Authors: Samaan, MA; Pavlidis, P; Johnston, E; Warner, B; Digby-Bell, J; Koumoutsos, I; Fong, S; Goldberg, R; Gulati, S; Medcalf, L; Sastrillo, M; Bedwell, T; Brown-Clarke, C; Bidwell-Sullivan, J; Forsyth, K; Lee, E; Stanton, A; Duncan, J; Chung-Faye, G; Dubois, P Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗